Retrospective Cohort Study of Methotrexate Use in the Treatment of Pediatric Crohnʼs Disease
2014; Oxford University Press; Volume: 20; Issue: 8 Linguagem: Inglês
10.1097/mib.0000000000000102
ISSN1536-4844
AutoresWhitney M. Sunseri, Jeffrey S. Hyams, Trudy Lerer, David Mack, Anne M. Griffiths, Anthony Otley, Joel R. Rosh, Ryan Carvalho, Andrew B. Grossman, José Cabrera, Marian D. Pfefferkorn, James Rick, Neal S. LeLeiko, Meredith C. Hitch, Maria Oliva‐Hemker, Shehzad A. Saeed, Michael D. Kappelman, James Markowitz, David J. Keljo,
Tópico(s)Autoimmune and Inflammatory Disorders Research
ResumoBackgroundMethotrexate (MTX) use as an alternative to thiopurines in the treatment of Crohn's disease (CD) in children is increasing. This study was undertaken to assess safety and efficacy of MTX in children with CD.
Referência(s)